Javascript must be enabled to continue!
DMN network and neurocognitive changes associated with dissociative symptoms in major depressive disorder: a research protocol
View through CrossRef
IntroductionDepression is a heterogeneous disorder with diverse clinical presentations and etiological underpinnings, necessitating the identification of distinct subtypes to enhance targeted interventions. Dissociative symptoms, commonly observed in major depressive disorder (MDD) and linked to early life trauma, may represent a unique clinical dimension associated with specific neurocognitive deficits. Although emerging research has begun to explore the role of dissociation in depression, most studies have provided only descriptive analyses, leaving the mechanistic interplay between these phenomena underexplored. The primary objective of this study is to determine whether MDD patients with prominent dissociative symptoms differ from those without such symptoms in clinical presentation, neurocognitive performance, and markers of functional connectivity. This investigation will be the first to integrate comprehensive clinical evaluations, advanced neurocognitive testing, and high-resolution brain imaging to delineate the contribution of dissociative symptoms in MDD.MethodsWe will recruit fifty participants for each of three groups: (1) depressive patients with dissociative symptoms, (2) depressive patients without dissociative symptoms, and (3) healthy controls. Diagnostic assessments will be performed using the Structured Clinical Interview for DSM-5 (SCID) alongside standardized scales for depression severity, dissociation, and childhood trauma. Neurocognitive performance will be evaluated through a battery of tests assessing memory, attention, executive function, and processing speed. Structural and functional magnetic resonance imaging (MRI) will be conducted on a 3 Tesla scanner, focusing on the connectivity of the Default Mode Network with key regions such as the orbitofrontal cortex, insula, and posterior cingulate cortex. Data analyses will employ SPM-12 and Matlab-based CONN and PRONTO tools, with multiclass Gaussian process classification applied to differentiate the three groups based on clinical, cognitive, and imaging data.DiscussionThe results of this study will introduce a novel perspective on understanding the connection between major depressive disorder and dissociation. It could also aid in pinpointing a distinct form of depression associated with dissociative symptoms and early childhood stressors.ConclusionFuture research, aiming to forecast the response to biological and psychological interventions for depression, anticipates this subtype and provides insights.
Title: DMN network and neurocognitive changes associated with dissociative symptoms in major depressive disorder: a research protocol
Description:
IntroductionDepression is a heterogeneous disorder with diverse clinical presentations and etiological underpinnings, necessitating the identification of distinct subtypes to enhance targeted interventions.
Dissociative symptoms, commonly observed in major depressive disorder (MDD) and linked to early life trauma, may represent a unique clinical dimension associated with specific neurocognitive deficits.
Although emerging research has begun to explore the role of dissociation in depression, most studies have provided only descriptive analyses, leaving the mechanistic interplay between these phenomena underexplored.
The primary objective of this study is to determine whether MDD patients with prominent dissociative symptoms differ from those without such symptoms in clinical presentation, neurocognitive performance, and markers of functional connectivity.
This investigation will be the first to integrate comprehensive clinical evaluations, advanced neurocognitive testing, and high-resolution brain imaging to delineate the contribution of dissociative symptoms in MDD.
MethodsWe will recruit fifty participants for each of three groups: (1) depressive patients with dissociative symptoms, (2) depressive patients without dissociative symptoms, and (3) healthy controls.
Diagnostic assessments will be performed using the Structured Clinical Interview for DSM-5 (SCID) alongside standardized scales for depression severity, dissociation, and childhood trauma.
Neurocognitive performance will be evaluated through a battery of tests assessing memory, attention, executive function, and processing speed.
Structural and functional magnetic resonance imaging (MRI) will be conducted on a 3 Tesla scanner, focusing on the connectivity of the Default Mode Network with key regions such as the orbitofrontal cortex, insula, and posterior cingulate cortex.
Data analyses will employ SPM-12 and Matlab-based CONN and PRONTO tools, with multiclass Gaussian process classification applied to differentiate the three groups based on clinical, cognitive, and imaging data.
DiscussionThe results of this study will introduce a novel perspective on understanding the connection between major depressive disorder and dissociation.
It could also aid in pinpointing a distinct form of depression associated with dissociative symptoms and early childhood stressors.
ConclusionFuture research, aiming to forecast the response to biological and psychological interventions for depression, anticipates this subtype and provides insights.
Related Results
Generación de modelos de procesos y decisiones a partir de documentos de texto
Generación de modelos de procesos y decisiones a partir de documentos de texto
(English) This thesis addresses the importance of formal models for the efficient management of business processes (BPM) and business decision management (BDM) in a constantly evol...
Graph analysis uncovers an opposing impact of methylphenidate on connectivity patterns within default mode network sub-divisions
Graph analysis uncovers an opposing impact of methylphenidate on connectivity patterns within default mode network sub-divisions
Abstract
Background
The Default Mode Network (DMN) is a central neural network, with recent evidence indicating that it is composed of functionally ...
A protocol for managing dissociative symptoms in refugee populations
A protocol for managing dissociative symptoms in refugee populations
AbstractThis article describes a clinical protocol for supporting those presenting with post-traumatic stress disorder (PTSD) and dissociative symptoms, particularly dissociative f...
Stress and Depressive Symptoms in College Students: The Sequential Mediating Roles of Emotion Dysregulation and Anxiety (Preprint)
Stress and Depressive Symptoms in College Students: The Sequential Mediating Roles of Emotion Dysregulation and Anxiety (Preprint)
BACKGROUND
Depressive symptoms (DPS) are a prevalent mental health concern among college students. Stress (STR) has been widely identified as an important correla...
Stress and Depressive Symptoms in College Students: The Sequential Mediating Roles of Emotion Dysregulation and Anxiety (Preprint)
Stress and Depressive Symptoms in College Students: The Sequential Mediating Roles of Emotion Dysregulation and Anxiety (Preprint)
BACKGROUND
Depressive symptoms (DPS) are a prevalent mental health concern among college students. Stress (STR) has been widely identified as an important correla...
PTSD Specific Deficits in Default Mode Network Strength: At Baseline and Following Experimental Stress
PTSD Specific Deficits in Default Mode Network Strength: At Baseline and Following Experimental Stress
Abstract
Reductions in default mode (DMN) connectivity strength have been reported in posttraumatic stress disorder (PTSD). However, the specificity of DMN connectivity def...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...

